3/20
11:24 am
mdgl
Rating for MDGL
Low
Report
Rating for MDGL
3/15
01:08 pm
mdgl
Rating for MDGL
Low
Report
Rating for MDGL
3/15
11:09 am
mdgl
Rating for MDGL
Low
Report
Rating for MDGL
3/15
11:09 am
mdgl
Rating for MDGL
Low
Report
Rating for MDGL
3/15
08:26 am
mdgl
Rating for MDGL
High
Report
Rating for MDGL
3/15
08:26 am
mdgl
Rating for MDGL
High
Report
Rating for MDGL
3/15
08:15 am
mdgl
Rating for MDGL
High
Report
Rating for MDGL
3/15
07:43 am
mdgl
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) was upgraded by analysts at B. Riley from a "sell" rating to a "neutral" rating. They now have a $270.00 price target on the stock, up previously from $155.00.
High
Report
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) was upgraded by analysts at B. Riley from a "sell" rating to a "neutral" rating. They now have a $270.00 price target on the stock, up previously from $155.00.
3/15
07:43 am
mdgl
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) was upgraded by analysts at B. Riley from a "sell" rating to a "neutral" rating. They now have a $270.00 price target on the stock, up previously from $155.00.
High
Report
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) was upgraded by analysts at B. Riley from a "sell" rating to a "neutral" rating. They now have a $270.00 price target on the stock, up previously from $155.00.
3/15
07:01 am
mdgl
Rating for MDGL
High
Report
Rating for MDGL
3/15
07:01 am
mdgl
Rating for MDGL
High
Report
Rating for MDGL
3/8
12:14 pm
mdgl
Rating for MDGL
Low
Report
Rating for MDGL
3/6
05:21 am
mdgl
Rating for MDGL
Low
Report
Rating for MDGL
3/6
05:21 am
mdgl
Rating for MDGL
Low
Report
Rating for MDGL
3/1
11:14 am
mdgl
Rating for MDGL
Medium
Report
Rating for MDGL
3/1
11:14 am
mdgl
Rating for MDGL
Medium
Report
Rating for MDGL
2/26
10:26 am
mdgl
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) was downgraded by analysts at B. Riley from a "neutral" rating to a "sell" rating. They now have a $155.00 price target on the stock.
Low
Report
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) was downgraded by analysts at B. Riley from a "neutral" rating to a "sell" rating. They now have a $155.00 price target on the stock.
2/26
10:26 am
mdgl
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) was downgraded by analysts at B. Riley from a "neutral" rating to a "sell" rating. They now have a $155.00 price target on the stock.
Low
Report
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) was downgraded by analysts at B. Riley from a "neutral" rating to a "sell" rating. They now have a $155.00 price target on the stock.
2/23
01:08 pm
mdgl
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $347.00 price target on the stock.
Low
Report
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $347.00 price target on the stock.
2/23
01:08 pm
mdgl
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $347.00 price target on the stock.
Low
Report
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $347.00 price target on the stock.
2/23
12:36 pm
mdgl
Rating for MDGL
Medium
Report
Rating for MDGL
2/23
12:36 pm
mdgl
Rating for MDGL
Medium
Report
Rating for MDGL
2/16
03:40 pm
mdgl
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $347.00 price target on the stock.
Low
Report
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $347.00 price target on the stock.
2/16
03:40 pm
mdgl
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $347.00 price target on the stock.
Low
Report
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $347.00 price target on the stock.
2/16
02:44 pm
mdgl
Rating for MDGL
Medium
Report
Rating for MDGL